|
Code
|
2520C
|
|
MA number
|
16/0006/17-S
|
|
Product Form:
|
tbl ent 100x100 mg (blis.PVC/Al)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Decentralised
|
|
MAH, country:
|
KRKA, d.d., Novo mesto, Slovenia
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B01 |
ANTITHROMBOTIC AGENTS |
| B01A |
ANTITHROMBOTIC AGENTS |
| B01AC |
Platelet aggregation inhibitors excl. heparin |
| B01AC06 |
Acetylsalicylic acid |
|
|
Shelf life:
|
36 |
|
Route of admin.:
|
Oral use
|
SPC_Abrea_75 mg_100 mg_160 mg_06.2023.pdf
